Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Pediatric Sepsis Program, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Crit Care Med. 2020 Mar;48(3):344-352. doi: 10.1097/CCM.0000000000004091.
Systemic endothelial activation may contribute to sepsis-associated organ injury, including acute respiratory distress syndrome. We hypothesized that children with extrapulmonary sepsis with versus without acute respiratory distress syndrome would have plasma biomarkers indicative of increased endothelial activation and that persistent biomarker changes would be associated with poor outcome.
Observational cohort.
Academic PICU.
Patients less than 18 years old with sepsis from extrapulmonary infection with (n = 46) or without (n = 54) acute respiratory distress syndrome and noninfected controls (n = 19).
None.
Endothelial (angiopoietin-1, angiopoietin-2, tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2, vascular endothelial growth factor, soluble fms-like tyrosine kinase, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin) and inflammatory biomarkers (C-reactive protein, interleukin-6, and interleukin-8) were measured from peripheral plasma collected within 3 days (time 1) of sepsis recognition and at 3-6 days (time 2) and 7-14 days (time 3). Time 1 biomarkers and longitudinal measurements were compared for sepsis patients with versus without acute respiratory distress syndrome and in relation to complicated course, defined as greater than or equal to two organ dysfunctions at day 7 or death by day 28. Angiopoietin-2, angiopoietin-2/angiopoietin-1 ratio, tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2, vascular endothelial growth factor, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin, endocan, C-reactive protein, interleukin-6, and interleukin-8 were different between sepsis and noninfected control patients at time 1. Among patients with sepsis, those with acute respiratory distress syndrome had higher angiopoietin-2/angiopoietin-1 ratio, vascular endothelial growth factor, vascular cell adhesion molecule, thrombomodulin, endocan, interleukin-6, and interleukin-8 than those without acute respiratory distress syndrome (all p < 0.003). Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio remained higher in sepsis with versus without acute respiratory distress syndrome after multivariable analyses. Time 1 measures of angiopoietin-2, angiopoietin-2/-1 ratio, von Willebrand factor, and endocan were indicative of complicated course in all sepsis patients (all area under the receiver operating curve ≥ 0.80). In sepsis without acute respiratory distress syndrome, soluble fms-like tyrosine kinase decreased more quickly and von Willebrand factor and thrombomodulin decreased more slowly in those with complicated course.
Children with extrapulmonary sepsis with acute respiratory distress syndrome had plasma biomarkers indicative of greater systemic endothelial activation than those without acute respiratory distress syndrome. Several endothelial biomarkers measured near sepsis recognition were associated with complicated course, whereas longitudinal biomarker changes yielded prognostic information only in those without sepsis-associated acute respiratory distress syndrome.
全身性内皮细胞激活可能导致脓毒症相关器官损伤,包括急性呼吸窘迫综合征。我们假设,伴有或不伴有急性呼吸窘迫综合征的肺部外脓毒症患儿的血浆生物标志物将显示内皮细胞激活增加,并且持续的生物标志物变化与不良预后相关。
观察性队列研究。
学术性儿科重症监护病房。
年龄小于 18 岁的肺部外感染性脓毒症患儿(急性呼吸窘迫综合征伴脓毒症,n=46;急性呼吸窘迫综合征不伴脓毒症,n=54)和非感染性对照组患儿(n=19)。
无。
在脓毒症发病后 3 天内(时间 1)和 3-6 天(时间 2)和 7-14 天(时间 3),采集外周血样,检测内皮(血管生成素-1、血管生成素-2、酪氨酸激酶免疫球蛋白样环表皮生长因子同源域 2、血管内皮生长因子、可溶性 fms 样酪氨酸激酶、血管性血友病因子、E-选择素、细胞间黏附分子、血管细胞黏附分子、血栓调节蛋白)和炎症生物标志物(C 反应蛋白、白细胞介素-6 和白细胞介素-8)。比较伴有和不伴有急性呼吸窘迫综合征的脓毒症患儿的时间 1 生物标志物和纵向测量值,并与复杂病程相关,定义为第 7 天至少有两个器官功能障碍或第 28 天死亡。在时间 1 时,血管生成素-2、血管生成素-2/血管生成素-1 比值、酪氨酸激酶免疫球蛋白样环表皮生长因子同源域 2、血管内皮生长因子、血管性血友病因子、E-选择素、细胞间黏附分子、血管细胞黏附分子、血栓调节蛋白、内皮下细胞蛋白、C 反应蛋白、白细胞介素-6 和白细胞介素-8 在脓毒症与非感染性对照组患儿之间存在差异。在脓毒症患儿中,伴有急性呼吸窘迫综合征的患儿的血管生成素-2/血管生成素-1 比值、血管内皮生长因子、血管细胞黏附分子、血栓调节蛋白、内皮下细胞蛋白、白细胞介素-6 和白细胞介素-8 高于不伴有急性呼吸窘迫综合征的患儿(所有 p<0.003)。多变量分析后,在伴有和不伴有急性呼吸窘迫综合征的脓毒症患儿中,血管生成素-2 和血管生成素-2/血管生成素-1 比值仍较高。在所有脓毒症患儿中,时间 1 的血管生成素-2、血管生成素-2/血管生成素-1 比值、血管性血友病因子和内皮下细胞蛋白均为复杂病程的标志物(所有受试者工作特征曲线下面积≥0.80)。在无急性呼吸窘迫综合征的脓毒症中,可溶性 fms 样酪氨酸激酶的下降速度较快,而血管性血友病因子和血栓调节蛋白的下降速度较慢。
伴有急性呼吸窘迫综合征的肺部外脓毒症患儿的血浆生物标志物显示出比不伴有急性呼吸窘迫综合征的患儿更大的全身性内皮细胞激活。在脓毒症发生后不久测量的几种内皮生物标志物与复杂病程相关,而纵向生物标志物变化仅在无脓毒症相关急性呼吸窘迫综合征的患儿中提供预后信息。